Literature DB >> 21852262

CA-125: a biomarker put to the test.

Charlie Schmidt.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21852262     DOI: 10.1093/jnci/djr344

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  Chronic Medical Conditions and CA125 Levels among Women without Ovarian Cancer.

Authors:  Babatunde O Akinwunmi; Ana Babic; Allison F Vitonis; Daniel W Cramer; Linda Titus; Shelley S Tworoger; Kathryn L Terry
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-09-20       Impact factor: 4.254

2.  The current and future status of biomarkers in osteoarthritis.

Authors:  David T Felson
Journal:  J Rheumatol       Date:  2014-05       Impact factor: 4.666

3.  Preoperative serum CA125 levels predict the prognosis in hyperbilirubinemia patients with resectable pancreatic ductal adenocarcinoma.

Authors:  Tao Chen; Min-Gui Zhang; Hua-Xiang Xu; Wen-Quan Wang; Liang Liu; Xian-Jun Yu
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

Review 4.  Biomarkers in pancreatic adenocarcinoma: current perspectives.

Authors:  Douglas S Swords; Matthew A Firpo; Courtney L Scaife; Sean J Mulvihill
Journal:  Onco Targets Ther       Date:  2016-12-09       Impact factor: 4.147

5.  Predictive equation of metastasis in patients with malignant ovarian epithelial tumors with the Ca-125 marker.

Authors:  Juan Fernando Sánchez Vega; Magdali Del Rocío Murillo Bacilio; Adrián Santiago Vintimilla Condoy; Araceli Miroslava Palta González; José Alfredo Crespo Astudillo; Franklin Geovany Mora-Bravo
Journal:  BMC Cancer       Date:  2018-05-24       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.